Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

Diego Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias M.P. Hartwich, Yang Yang‐Hartwich, Levent Mutlu, Margherita Zipponi, Cem Demirkiran, Miguel Skyler Z. Verzosa, Gary Altwerger, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, Peter Dottino, Jungmin Choi, Ludmil B. Alexandrov, Natália Buza, Pei Hui, Alessandro D. Santin